Abstract

Health Care Resource Use and Costs Pre- and Post-Treatment Initiation With Linaclotide: Retrospective Analyses of a U.S. Insured Population

Taylor DC1, Abel JL2, Bancroft T3, Buzinec P3, Goolsby Hunter A3, Carson RT2, Martin C3. Manag Care. 2018 Feb;27(2):33-40.
 
     

Author information

1 Ironwood Pharmaceuticals Inc., Cambridge, Mass.

2 Allergan plc, Jersey City, N.J.

3 Optum, Eden Prairie, Minn.

Abstract

As expected, pharmacy costs increased with the introduction of this new treatment in a market dominated by over-the-counter and generic treatments. On the other hand, outpatient GI-related and irritable bowel diseasehealth care resource use and costs substantially decreased among commercial and Medicare patients following linaclotide treatment initiation.

© Copyright 2013-2018 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.